Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Vildagliptin and Metformin


Affiliations
1 Department of Pharmaceutical Chemistry, Shivnagar Vidya Prasarak Mandals College of Pharmacy, Malegaon (Bk.), Tal- Baramati, Dist- Pune, Maharashtra-413115, India
2 Department of Pharmaceutical Analysis, Sinhgad College of Pharmacy, Vadgaon (Bk.), Off Sinhgad Road, Pune, Maharashtra-411041, India
3 Department of Pharmaceutics, Sinhgad College of Pharmacy, Vadgaon (Bk.), Off Sinhgad Road, Pune, Maharashtra-411041, India
     

   Subscribe/Renew Journal


A RP-HPLC method was developed and validated for the simultaneous estimation of Vildagliptin (VIDA) and Metformin Hydrochloride (MET) in bulk and pharmaceutical dosage form. Chromatography was carried on Warers HPLC, Lichrocart C18 column (250 x 4.60 x 5μm) with mobile phase comprising of 0.05 M KH2PO4 : Acetonitrile (70:30 v/v pH 3.5 with Ortho Phosphoric Acid). The flow rate was adjusted to 1.0 ml/min with UV detection at 215 nm. The retention times of VIDA and MET were found to be 6.64 and 5.18 minutes respectively. The different analytical parameters such as accuracy, linearity, precision, robustness, ruggedness were determined according to the ICH Q2B guidelines. The detector response was linear in the range of 5-25 μg/ml, 10-50 μg/ml for VIDA and MET respectively. In the linearity study, the regression equation and correlation of coefficient for VIDA and MET were found to be (y = 1014x + 54.43, R2 = 0.999) and (y = 307.8x + 146.0, R2 = 0.999) respectively. The proposed method is highly sensitive, precise and accurate. Hence this method developed successfully and applied for the routine quantification of active pharmaceuticals present in the commercial formulations.

Keywords

Vildagliptin, Metformin, Simultaneous Estimation, Hypoglycemic Agents, HPLC.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 252

PDF Views: 0




  • Development and Validation of RP-HPLC Method for Simultaneous Estimation of Vildagliptin and Metformin

Abstract Views: 252  |  PDF Views: 0

Authors

Shrikrishna B. Baokar
Department of Pharmaceutical Chemistry, Shivnagar Vidya Prasarak Mandals College of Pharmacy, Malegaon (Bk.), Tal- Baramati, Dist- Pune, Maharashtra-413115, India
Sugandha V. Mulgund
Department of Pharmaceutical Analysis, Sinhgad College of Pharmacy, Vadgaon (Bk.), Off Sinhgad Road, Pune, Maharashtra-411041, India
Nisharani S. Ranpise
Department of Pharmaceutics, Sinhgad College of Pharmacy, Vadgaon (Bk.), Off Sinhgad Road, Pune, Maharashtra-411041, India

Abstract


A RP-HPLC method was developed and validated for the simultaneous estimation of Vildagliptin (VIDA) and Metformin Hydrochloride (MET) in bulk and pharmaceutical dosage form. Chromatography was carried on Warers HPLC, Lichrocart C18 column (250 x 4.60 x 5μm) with mobile phase comprising of 0.05 M KH2PO4 : Acetonitrile (70:30 v/v pH 3.5 with Ortho Phosphoric Acid). The flow rate was adjusted to 1.0 ml/min with UV detection at 215 nm. The retention times of VIDA and MET were found to be 6.64 and 5.18 minutes respectively. The different analytical parameters such as accuracy, linearity, precision, robustness, ruggedness were determined according to the ICH Q2B guidelines. The detector response was linear in the range of 5-25 μg/ml, 10-50 μg/ml for VIDA and MET respectively. In the linearity study, the regression equation and correlation of coefficient for VIDA and MET were found to be (y = 1014x + 54.43, R2 = 0.999) and (y = 307.8x + 146.0, R2 = 0.999) respectively. The proposed method is highly sensitive, precise and accurate. Hence this method developed successfully and applied for the routine quantification of active pharmaceuticals present in the commercial formulations.

Keywords


Vildagliptin, Metformin, Simultaneous Estimation, Hypoglycemic Agents, HPLC.